Clinical Trials Logo

Lipodystrophy clinical trials

View clinical trials related to Lipodystrophy.

Filter by:

NCT ID: NCT03966924 Completed - Lipodystrophy Clinical Trials

The PREFORM Study: Rotational Fractional Resection for Submental Contouring

Start date: March 20, 2019
Phase: N/A
Study type: Interventional

This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring. Rotational fractional resection is used to remove loose skin and fat.

NCT ID: NCT03826160 Completed - Clinical trials for Human Immunodeficiency Virus

Growth Hormone Dynamics and Cardiac Steatosis in HIV

Start date: January 30, 2019
Phase:
Study type: Observational

Cardiac steatosis is increased among individuals with HIV, and may predispose to cardiac mechanical dysfunction and subsequent heart failure. The pathogenesis and treatment of cardiac steatosis is not well understood. The investigators have previously shown that perturbed growth hormone (GH) secretion in HIV contributes to ectopic fat accumulation in the viscera and the liver. Moreover, the investigators have found that augmentation of endogenous GH secretion with the FDA-approved medication tesamorelin reduces visceral and hepatic fat. In this longitudinal observational study, the investigators will examine patients with HIV and abdominal fat accumulation who either plan or do not plan to initiate tesamorelin prescribed clinically. The investigators hypothesize that blunted GH secretion in HIV is associated with cardiac steatosis. The investigators also hypothesize that use of tesamorelin for 6 months is associated with a reduction in intramyocardial fat and preserved cardiac function.

NCT ID: NCT03817840 Completed - Cushing's Syndrome Clinical Trials

Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease

Start date: July 16, 2018
Phase:
Study type: Observational

This proposal will evaluate the glucocorticoid mediated changes in body fat distribution and metabolism that occur in patients with Cushing's disease. The objective is to identify the mechanisms that influence both the accumulation of lipodystrophic fat and also the changes in energy expenditure and metabolism that accompany them. The study is designed to determine if the high cortisol and AgRP levels in the blood of people living with Cushing's syndrome, either from taking steroid medications or from tumors, impact body fat and metabolism by turning off brown fat, which is a type of fat that increases one's metabolism.

NCT ID: NCT03514420 Completed - Clinical trials for Familial Partial Lipodystrophy

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Start date: June 15, 2018
Phase: Phase 2
Study type: Interventional

This is a single-center, open-label study to evaluate the efficacy of AKCEA-ANGPTL3-LRx for reduction of fasting triglycerides in participants with familial partial lipodystrophy.

NCT ID: NCT03508687 Completed - Clinical trials for Hypertriglyceridemia

Study of Gemcabene in Adults With FPLD

Start date: March 13, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

The overall objective of this study is to assess the efficacy and safety of two dosing regimens of gemcabene (300 mg once daily for 24 weeks or 300 mg daily for 12 weeks followed by 600 mg daily for 12 weeks) in up to eight patients with Familial Partial Lipodystrophy with high triglycerides and Non-Alcoholic Fatty Liver Disease. The study will consist of a six week Wash Out Period, up to a 28 day Screening Period, a 24 week Treatment Period, and a follow-on safety assessment four weeks post final dose. Study participation will last approximately 4 months and includes at least 9 study visits, and can be as many as 11 study visits.

NCT ID: NCT03445351 Completed - Lipodystrophy Clinical Trials

Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS

PLHA
Start date: January 20, 2013
Phase: N/A
Study type: Interventional

Aim: Evaluate the influence of exercise, in different times, on quality of life, sleep and clinical parameters in people living with HIV/AIDS (PLHA). Methods: Intervention study, prospective.

NCT ID: NCT03407313 Completed - Lipodystrophy Clinical Trials

CONFORM: Rotational Fractional Resection for Submental Contouring

Start date: January 8, 2018
Phase: N/A
Study type: Interventional

This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring. RFR is used to remove loose skin and fat.

NCT ID: NCT03275259 Completed - Adiposity Clinical Trials

Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat

ESWT
Start date: April 3, 2017
Phase: N/A
Study type: Interventional

PURPOSE: To evaluate the efficacy of shock waves extracorporea in improving body contour,decrease fat localized and appearance of gynoid lipodystrophy. SUBJECTS AND METHODS: A prospective and comparative longitudinal clinical study will be performed in 30 women with localized fat and gynoid lipodystrophy. Patients will be submitted data collection and assessments and before and after treatment. HYPOTHESES: It is expected that the patients will present improvement in the body contour, decrease fat localized and in the picture of the gynoid lipodystrophy after of the therapies. STATISTICAL ANALYSIS: A descriptive analysis will be done before and after vibration-oscillatory therapy, with frequency tables for categorical and descriptive variables (mean, standard deviation, median, minimum and maximum values) for continuous or numerical variables. In order to compare the main variables between the groups and the collection times, the analysis of variance (ANOVA) for repeated measurements will be used. Tukey's test will be used to compare groups. The level of significance adopted for the statistical tests will be 5% or p <0.05.

NCT ID: NCT03262610 Completed - Obesity Clinical Trials

Setmelanotide in a Single Patient With Partial Lipodystrophy

Start date: August 15, 2017
Phase: Phase 2
Study type: Interventional

The objective of this single patient study is to assess the safety and efficacy of setmelanotide as a treatment of severe metabolic abnormalities resulting from LD, especially refractory hypertriglyceridemia leading to recurrent bouts of pancreatitis.

NCT ID: NCT03075332 Completed - Sarcopenia Clinical Trials

Detraining in People Living With HIV/AIDS

PVHA
Start date: February 19, 2016
Phase: N/A
Study type: Interventional

The goal of this study was to evaluate the effect of detraining in the components of physical aptitude of people living with HIV/Aids (PVHA).